## VRSK: Verisk Analytics, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%); PEG 2.78 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($213.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. The Truth About Verisk Analytics Inc: Why Wall Street Is Quietly Obsessed**
- Source: AD HOC NEWS | 20260106T090855 | Somewhat-Bullish | Relevance: 100%
- Verisk Analytics Inc (VRSK) is gaining quiet obsession on Wall Street, despite not being a "sexy" meme stock. The article highlights its steady long-term uptrend, recurring revenue, and strong position in providing high-value data and analytics to the insurance and risk industries. While not flashy, VRSK is presented as a high-quality, low-drama compounder for long-term investors comfortable with its premium valuation.

**2. Railway Pension Investments Ltd Increases Stake in Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20260105T123016 | Somewhat-Bullish | Relevance: 100%
- Railway Pension Investments Ltd significantly increased its stake in Verisk Analytics, Inc. (NASDAQ:VRSK) by 24.0% in Q3, adding 11,900 shares and bringing its total holdings to 61,400 shares valued at $15.443 million. Institutional investors now own approximately 90.0% of VRSK, with corporate insiders holding a much smaller 0.46%. Verisk reported Q3 EPS of $1.72, beating estimates, and offered FY2025 EPS guidance, while analysts currently rate the stock as a "Hold" with an average price target of $278.64.

**3. Verisk Ends Effort to Acquire AccuLynx**
- Source: citybiz | 20260104T130822 | Somewhat-Bearish | Relevance: 100%
- Verisk (Nasdaq: VRSK) announced the termination of its agreement to acquire AccuLynx following notification from the Federal Trade Commission (FTC) that its review of the transaction had not been completed by the stipulated December 26, 2025 termination date. Verisk will redeem $1.50 billion in senior notes issued for the planned acquisition and strongly disagrees with AccuLynx's assertion that the termination is invalid. Verisk's CEO, Lee Shavel, reaffirmed the company's commitment to capital allocation discipline and achieving long-term growth targets.

**4. 1 Cash-Producing Stock with Solid Fundamentals and 2 That Underwhelm**
- Source: Finviz | 20260104T234100 | Somewhat-Bearish | Relevance: 81%
- This article analyzes three companies based on their cash flow and shareholder value creation. It recommends "selling" UFP Industries (UFPI) and Verisk (VRSK) due to declining sales, profitability issues, and slow growth compared to peers for the former, and slow revenue and EPS growth for the latter. Conversely, Accenture (ACN) is highlighted as a "stock to watch" because of its strong revenue growth, substantial market presence, and high return on capital.

**5. Q3 Earnings Roundup: Fair Isaac Corporation (NYSE:FICO) And The Rest Of The Data & Business Process Services Segment**
- Source: Finviz | 20260104T223600 | Somewhat-Bearish | Relevance: 64%
- This article reviews the Q3 earnings for Fair Isaac Corporation (FICO) and other companies in the data & business process services sector, highlighting strong revenue beats overall. Fair Isaac Corporation delivered in-line revenues but weaker full-year guidance, while Planet Labs (PL) had the strongest Q3 performance, and Verisk (VRSK) presented the weakest. The sector generally benefited from increased data reliance and outsourcing, navigating headwinds from regulatory scrutiny and cyber threats.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $270 | $290 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.31M) |
| Sells | 5 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+2.0%)
- Blackrock Inc.: 9.4% (+5.5%)
- State Street Corpora: 4.3% (-1.3%)
- Alliancebernstein L.: 3.8% (+3.1%)
- FMR, LLC: 3.1% (-22.9%)

### Key Risks

1. Long-term trend broken: trading 17.3% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.78 signals overvaluation risk, limited margin of safety. Forward P/E 28.9x stretched relative to 10% growth. Quality metrics strong (ROE 268%, ROA 16%, margin 30%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $30.9B |
| Beta | 0.81 |
| 52W Range | $197.00 - $322.92 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.78 |
| Forward P/E | 28.9 |
| Current P/E | 31.9 |
| YoY Growth | 10.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.5% to -0.5% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). Underperforming sector by 3.3pp, stock-specific weakness. Below SMA200 (0.83x), long-term trend not supportive. RSI neutral at 50. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.48% (CS: 30) | Neutral |
| RSI_14 | 50.4 | Neutral |
| MACD Histogram | 0.48 | Bullish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 1.005x | Above |
| vs SMA200 | 0.827x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $221.23
- **Stop Loss:** $213.01 (3.7% risk)
- **Target:** $229.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 160
- **Position Value:** $35,396.80
- **Portfolio %:** 35.40%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-25 (Est: $1.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.70 | $1.72 | +1.0% |
| 2025Q2 | $1.77 | $1.88 | +6.1% |
| 2025Q1 | $1.68 | $1.73 | +2.8% |
| 2024Q4 | $1.60 | $1.61 | +0.8% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*